Drug firm Strides Shasun today reported a consolidated net profit at Rs 96.22 crore for the fourth quarter ended March 31, 2016 on account of robust sales.
The company had posted a net profit after taxes and minority interest of Rs 11.39 crore for the same period a year ago, Strides Shasun said in a BSE filing.
Consolidated total income from operations stood at Rs 1,001.98 crore for the quarter under review. It was Rs 335.78 crore in the corresponding period of the previous fiscal.
For the fiscal ended March 31, 2016, the company had posted a net profit of Rs 208.92 crore whereas for the previous fiscal it was Rs 844.99 crore.
Consolidated total income from operations of the company stood at Rs 3,156.35 crore for the 2015-16 fiscal. It was Rs 1,195.84 crore for the previous fiscal.
Strides Shasun Executive Vice Chairman and MD Arun Kumar said: "We closed out fiscal year 2016 on a high note with a milestone quarter and a strong business momentum despite a weak performance from our emerging market operations."
In a separate filing Strides Shasun said its board has recommended a dividend of 40 per cent at Rs 4 per share for the year ended March 31, 2016.
Shares of Strides Shasun today closed at Rs 1,192.55 per scrip on BSE, up 0.24 per cent from its previous close.
